These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 2053129

  • 1. Area under the curve monitoring of cyclosporine therapy: the early posttransplant period.
    Grevel J, Kahan BD.
    Ther Drug Monit; 1991 Mar; 13(2):89-95. PubMed ID: 2053129
    [Abstract] [Full Text] [Related]

  • 2. Area-under-the-curve monitoring of cyclosporine therapy: performance of different assay methods and their target concentrations.
    Grevel J, Napoli KL, Gibbons S, Kahan BD.
    Ther Drug Monit; 1990 Jan; 12(1):8-15. PubMed ID: 2406998
    [Abstract] [Full Text] [Related]

  • 3. The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation.
    Kahan BD, Welsh M, Rutzky L, Lewis R, Knight R, Katz S, Napoli K, Grevel J, Van Buren CT.
    Transplantation; 1992 Feb; 53(2):345-51. PubMed ID: 1738928
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring.
    Grevel J, Welsh MS, Kahan BD.
    Ther Drug Monit; 1989 Feb; 11(3):246-8. PubMed ID: 2658210
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetically determined cyclosporine dosage in young children.
    Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL.
    Pediatr Nephrol; 1991 Jan; 5(1):1-4. PubMed ID: 2025515
    [Abstract] [Full Text] [Related]

  • 6. Steady-state concentrations of cyclosporine for therapeutic monitoring.
    Grevel J, Napoli KL, Kahan BD.
    Transplant Proc; 1990 Jun; 22(3):1339-42. PubMed ID: 2190397
    [No Abstract] [Full Text] [Related]

  • 7. Cyclosporine pharmacokinetics in the early course of renal transplantation.
    Albrecht K, Niebel W, Marggraf G, Eigler FW.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1719. PubMed ID: 3274413
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and clinical tolerance of intravenous and oral cyclosporine in the immediate postoperative period.
    Morse GD, Holdsworth MT, Venuto RC, Gerbasi J, Walshe JJ.
    Clin Pharmacol Ther; 1988 Dec; 44(6):654-64. PubMed ID: 3058372
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine dose reduction by ketoconazole administration in renal transplant recipients.
    First MR, Schroeder TJ, Alexander JW, Stephens GW, Weiskittel P, Myre SA, Pesce AJ.
    Transplantation; 1991 Feb; 51(2):365-70. PubMed ID: 1994529
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of constant-rate intravenous cyclosporine infusion immediately after heart transplantation.
    Schroeder TJ, Myre SA, Melvin DB, Van der Bel-Kahn J, Stephens GW, Collins JA, Wolf RK, Brown LL, Pesce AJ, First MR.
    J Heart Transplant; 1989 Feb; 8(1):5-10. PubMed ID: 2647932
    [Abstract] [Full Text] [Related]

  • 11. Determination of cyclosporine concentrations with monoclonal antibodies.
    Schran HF, Rosano TG, Hassell AE, Pell MA.
    Clin Chem; 1987 Dec; 33(12):2225-9. PubMed ID: 3319290
    [Abstract] [Full Text] [Related]

  • 12. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ, Venkataramanan R, Rosenthal JT, Burckart GJ, Taylor RJ, Hakala TR.
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of cyclosporine G in patients with renal failure.
    Wenk M, Bindschedler M, Costa E, Zuber M, Vozeh S, Thiel G, Abisch E, Keller HP, Beveridge T, Follath F.
    Transplantation; 1988 Mar; 45(3):558-61. PubMed ID: 3347936
    [Abstract] [Full Text] [Related]

  • 14. [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].
    Ramon M, Morel D, Penouil F, Grellet J, Potaux L, Saux MC, Brachet-Liermain A.
    Therapie; 1989 Mar; 44(5):371-4. PubMed ID: 2814916
    [Abstract] [Full Text] [Related]

  • 15. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
    Dupuis LL, Seto W, Teuffel O, Gibson P, Schultz KR, Doyle JD, Gassas A, Egeler RM, Sung L, Schechter T.
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
    [Abstract] [Full Text] [Related]

  • 16. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B, Gupta SK, Rowland M, Johnson RW, Solomon LR.
    Eur J Clin Pharmacol; 1988 Mar; 34(5):451-60. PubMed ID: 3203704
    [Abstract] [Full Text] [Related]

  • 17. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM, Kahan BD, Kaplan B, Lorber M, Winkler M, Rouilly M, Gerbeau C, Cambon N, Boger R, Rordorf C, Everolimus Phase 2 Study Group.
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine kinetics in healthy volunteers.
    Ptachcinski RJ, Venkataramanan R, Burckart GJ, Gray JA, Van Thiel DH, Sanghvi A, Rosenthal JT.
    J Clin Pharmacol; 1987 Mar; 27(3):243-8. PubMed ID: 3680581
    [Abstract] [Full Text] [Related]

  • 19. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy.
    Kahan BD, Grevel J.
    Transplantation; 1988 Nov; 46(5):631-44. PubMed ID: 3057685
    [Abstract] [Full Text] [Related]

  • 20. The pharmacokinetics and colonic tissue concentrations of cyclosporine after i.v., oral, and enema administration.
    Sandborn WJ, Strong RM, Forland SC, Chase RE, Cutler RE.
    J Clin Pharmacol; 1991 Jan; 31(1):76-80. PubMed ID: 2045532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.